Skip to main content
Top
Published in: Neuroradiology 12/2010

01-12-2010 | Paediatric Neuroradiology

Three-dimensional susceptibility-weighted imaging and two-dimensional T2*-weighted gradient-echo imaging of intratumoral hemorrhages in pediatric diffuse intrinsic pontine glioma

Authors: Ulrike Löbel, Jan Sedlacik, Noah D. Sabin, Mehmet Kocak, Alberto Broniscer, Claudia M. Hillenbrand, Zoltán Patay

Published in: Neuroradiology | Issue 12/2010

Login to get access

Abstract

Introduction

We compared the sensitivity and specificity of T2*-weighted gradient-echo imaging (T2*-GRE) and susceptibility-weighted imaging (SWI) in determining prevalence and cumulative incidence of intratumoral hemorrhages in children with diffuse intrinsic pontine glioma (DIPG) undergoing antiangiogenic and radiation therapy.

Methods

Patients were recruited from an institutional review board-approved prospective phase I trial of vandetanib administered in combination with radiation therapy. Patient consent was obtained before enrollment. Consecutive T2*-GRE and SWI exams of 17 patients (F/M: 9/8; age 3–17 years) were evaluated. Two reviewers (R1 and R2) determined the number and size of hemorrhages at baseline and multiple follow-ups (92 scans, mean 5.4/patient). Statistical analyses were performed using descriptive statistics, graphical tools, and mixed-effects Poisson regression models.

Results

Prevalence of hemorrhages at diagnosis was 41% and 47%; the cumulative incidences of hemorrhages at 6 months by T2*-GRE and SWI were 82% and 88%, respectively. Hemorrhages were mostly petechial; 9.7% of lesions on T2*-GRE and 5.2% on SWI were hematomas (>5 mm). SWI identified significantly more hemorrhages than T2*-GRE did. Lesions were missed or misinterpreted in 36/39 (R1/R2) scans by T2*-GRE and 9/3 scans (R1/R2) by SWI. Hemorrhages had no clinically significant neurological correlates in patients.

Conclusions

SWI is more sensitive than T2*-GRE in detecting hemorrhages and differentiating them from calcification, necrosis, and artifacts. Also, petechial hemorrhages are more common in DIPG at diagnosis than previously believed and their number increases during the course of treatment; hematomas are rare.
Literature
1.
go back to reference CBTRUS (2005) Statistical Report: Primary Brain Tumors in the United States, 1998–2002. Central Brain Tumor Registry of the United States, Chicago CBTRUS (2005) Statistical Report: Primary Brain Tumors in the United States, 1998–2002. Central Brain Tumor Registry of the United States, Chicago
2.
go back to reference Kaatsch P, Rickert CH, Kuhl L, Schuz J, Michaelis J (2001) Population-based epidemiologic data on brain tumors in German children. Cancer 92:3155–3164CrossRefPubMed Kaatsch P, Rickert CH, Kuhl L, Schuz J, Michaelis J (2001) Population-based epidemiologic data on brain tumors in German children. Cancer 92:3155–3164CrossRefPubMed
3.
go back to reference Fischbein NJ, Prados MD, Wara W, Russo C, Edwards MSB, Barkovich AJ (1996) Radiologic classification of brain stem tumors: correlation of magnetic resonance imaging appearance with clinical outcome. Pediatr Neurosurg 24:9–23CrossRefPubMed Fischbein NJ, Prados MD, Wara W, Russo C, Edwards MSB, Barkovich AJ (1996) Radiologic classification of brain stem tumors: correlation of magnetic resonance imaging appearance with clinical outcome. Pediatr Neurosurg 24:9–23CrossRefPubMed
4.
go back to reference Hargrave D, Bartels U, Bouffet E (2006) Diffuse brainstem glioma in children: critical review of clinical trials. Lancet Oncol 7:241–248CrossRefPubMed Hargrave D, Bartels U, Bouffet E (2006) Diffuse brainstem glioma in children: critical review of clinical trials. Lancet Oncol 7:241–248CrossRefPubMed
5.
go back to reference Folkman J, Bach M, Rowe JW, Davidoff F, Lambert P, Hirsch C, Goldberg A, Hiatt HH, Glass J, Henshaw E (1971) Tumor angiogenesis - therapeutic implications. N Engl J Med 285:1182–1186CrossRefPubMed Folkman J, Bach M, Rowe JW, Davidoff F, Lambert P, Hirsch C, Goldberg A, Hiatt HH, Glass J, Henshaw E (1971) Tumor angiogenesis - therapeutic implications. N Engl J Med 285:1182–1186CrossRefPubMed
7.
go back to reference MacDonald TJ, Stewart CF, Kocak M, Goldman S, Ellenbogen RG, Phillips P, Lafond D, Poussaint TY, Kieran MW, Boyett JM, Kun LE (2008) Phase I clinical trial of cilengitide in children with refractory brain tumors: pediatric brain tumor consortium study PBTC-012. J Clin Oncol 26:919–924CrossRefPubMed MacDonald TJ, Stewart CF, Kocak M, Goldman S, Ellenbogen RG, Phillips P, Lafond D, Poussaint TY, Kieran MW, Boyett JM, Kun LE (2008) Phase I clinical trial of cilengitide in children with refractory brain tumors: pediatric brain tumor consortium study PBTC-012. J Clin Oncol 26:919–924CrossRefPubMed
8.
go back to reference Pollack IF, Jakacki RI, Blaney SM, Hancock ML, Kieran MW, Phillips P, Kun LE, Friedman H, Packer R, Banerjee A, Geyer JR, Goldman S, Poussaint TY, Krasin MJ, Wang YF, Hayes M, Murgo A, Weiner S, Boyett JM (2007) Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: a pediatric brain tumor consortium report. Neuro Oncol 9:145–160CrossRefPubMed Pollack IF, Jakacki RI, Blaney SM, Hancock ML, Kieran MW, Phillips P, Kun LE, Friedman H, Packer R, Banerjee A, Geyer JR, Goldman S, Poussaint TY, Krasin MJ, Wang YF, Hayes M, Murgo A, Weiner S, Boyett JM (2007) Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: a pediatric brain tumor consortium report. Neuro Oncol 9:145–160CrossRefPubMed
9.
go back to reference Pope WB, Lai A, Nghiemphu P, Mischel P, Cloughesy TF (2006) MRI in patients with high-grade gliomas treated with bevacizumab and chemotherapy. Neurology 66:1258–1260CrossRefPubMed Pope WB, Lai A, Nghiemphu P, Mischel P, Cloughesy TF (2006) MRI in patients with high-grade gliomas treated with bevacizumab and chemotherapy. Neurology 66:1258–1260CrossRefPubMed
10.
go back to reference Broniscer A, Laningham FH, Kocak M, Krasin MJ, Fouladi M, Merchant TE, Kun LE, Boyett JM, Gajjar A (2006) Intratumoral hemorrhage among children with newly diagnosed, diffuse brainstem glioma. Cancer 106:1364–1371CrossRefPubMed Broniscer A, Laningham FH, Kocak M, Krasin MJ, Fouladi M, Merchant TE, Kun LE, Boyett JM, Gajjar A (2006) Intratumoral hemorrhage among children with newly diagnosed, diffuse brainstem glioma. Cancer 106:1364–1371CrossRefPubMed
11.
go back to reference Reichenbach JR, Haacke EM (2001) High-resolution BOLD venographic imaging: a window into brain function. NMR Biomed 14:453–467CrossRefPubMed Reichenbach JR, Haacke EM (2001) High-resolution BOLD venographic imaging: a window into brain function. NMR Biomed 14:453–467CrossRefPubMed
12.
go back to reference Tong KA, Ashwal S, Obenaus A, Nickerson JP, Kido D, Haacke EM (2008) Susceptibility-weighted MR imaging: a review of clinical applications in children. AJNR Am J Neuroradiol 29:9–17CrossRefPubMed Tong KA, Ashwal S, Obenaus A, Nickerson JP, Kido D, Haacke EM (2008) Susceptibility-weighted MR imaging: a review of clinical applications in children. AJNR Am J Neuroradiol 29:9–17CrossRefPubMed
13.
go back to reference Gronemeyer SA, Langston JW, Hanna SL (1992) MR imaging detection of calcified intracranial lesions and differentiation from iron-laden lesions. J Magn Reson Imaging 2:271–276CrossRefPubMed Gronemeyer SA, Langston JW, Hanna SL (1992) MR imaging detection of calcified intracranial lesions and differentiation from iron-laden lesions. J Magn Reson Imaging 2:271–276CrossRefPubMed
14.
go back to reference Deistung A, Mentzel HJ, Rauscher A, Witoszynskyj S, Kaiser WA, Reichenbach JR (2006) Demonstration of paramagnetic and diamagnetic cerebral lesions by using susceptibility weighted phase imaging (SWI). Z Med Phys 16:261–267PubMed Deistung A, Mentzel HJ, Rauscher A, Witoszynskyj S, Kaiser WA, Reichenbach JR (2006) Demonstration of paramagnetic and diamagnetic cerebral lesions by using susceptibility weighted phase imaging (SWI). Z Med Phys 16:261–267PubMed
15.
16.
go back to reference Akter M, Hirai T, Hiai Y, Kitajima M, Komi M, Murakami R, Fukuoka H, Sasao A, Toya R, Haacke EM, Takahashi M, Hirano T, Kai Y, Morioka M, Hamasaki K, Kuratsu J, Yamashita Y (2007) Detection of hemorrhagic hypointense foci in the brain on susceptibility-weighted imaging clinical and phantom studies. Acad Radiol 14:1011–1019CrossRefPubMed Akter M, Hirai T, Hiai Y, Kitajima M, Komi M, Murakami R, Fukuoka H, Sasao A, Toya R, Haacke EM, Takahashi M, Hirano T, Kai Y, Morioka M, Hamasaki K, Kuratsu J, Yamashita Y (2007) Detection of hemorrhagic hypointense foci in the brain on susceptibility-weighted imaging clinical and phantom studies. Acad Radiol 14:1011–1019CrossRefPubMed
17.
go back to reference Liang LX, Korogi Y, Sugahara T, Shigematsu Y, Okuda T, Ikushima I, Takahashi M (1999) Detection of intracranial hemorrhage with susceptibility-weighted MR sequences. Am J Neuroradiol 20:1527–1534PubMed Liang LX, Korogi Y, Sugahara T, Shigematsu Y, Okuda T, Ikushima I, Takahashi M (1999) Detection of intracranial hemorrhage with susceptibility-weighted MR sequences. Am J Neuroradiol 20:1527–1534PubMed
18.
go back to reference Sehgal V, Delproposto Z, Haddar D, Haacke EM, Sloan AE, Zamorano LJ, Barger G, Hu J, Xu Y, Prabhakaran KP, Elangovan IR, Neelavalli J, Reichenbach JR (2006) Susceptibility-weighted imaging to visualize blood products and improve tumor contrast in the study of brain masses. J Magn Reson Imaging 24:41–51CrossRefPubMed Sehgal V, Delproposto Z, Haddar D, Haacke EM, Sloan AE, Zamorano LJ, Barger G, Hu J, Xu Y, Prabhakaran KP, Elangovan IR, Neelavalli J, Reichenbach JR (2006) Susceptibility-weighted imaging to visualize blood products and improve tumor contrast in the study of brain masses. J Magn Reson Imaging 24:41–51CrossRefPubMed
19.
go back to reference Wu Z, Mittal S, Kish K, Yu Y, Hu J, Haacke EM (2009) Identification of calcification with MRI using susceptibility-weighted imaging: a case study. J Magn Reson Imaging 29:177–182CrossRefPubMed Wu Z, Mittal S, Kish K, Yu Y, Hu J, Haacke EM (2009) Identification of calcification with MRI using susceptibility-weighted imaging: a case study. J Magn Reson Imaging 29:177–182CrossRefPubMed
20.
go back to reference Zhu WZ, Qi JP, Zhan CJ, Shu HG, Zhang L, Wang CY, Xia LM, Hu JW, Feng DY (2008) Magnetic resonance susceptibility weighted imaging in detecting intracranial calcification and hemorrhage. Chin Med J (Engl) 121:2021–2025 Zhu WZ, Qi JP, Zhan CJ, Shu HG, Zhang L, Wang CY, Xia LM, Hu JW, Feng DY (2008) Magnetic resonance susceptibility weighted imaging in detecting intracranial calcification and hemorrhage. Chin Med J (Engl) 121:2021–2025
21.
go back to reference Tong KA, Ashwal S, Holshouser BA, Nickerson JP, Wall CJ, Shutter LA, Osterdock RJ, Haacke EM, Kido D (2004) Diffuse axonal injury in children: clinical correlation with hemorrhagic lesions. Ann Neurol 56:36–50CrossRefPubMed Tong KA, Ashwal S, Holshouser BA, Nickerson JP, Wall CJ, Shutter LA, Osterdock RJ, Haacke EM, Kido D (2004) Diffuse axonal injury in children: clinical correlation with hemorrhagic lesions. Ann Neurol 56:36–50CrossRefPubMed
22.
go back to reference Hargrave D, Chuang N, Bouffet E (2008) Conventional MRI cannot predict survival in childhood diffuse intrinsic pontine glioma. J Neurooncol 86:313–319CrossRefPubMed Hargrave D, Chuang N, Bouffet E (2008) Conventional MRI cannot predict survival in childhood diffuse intrinsic pontine glioma. J Neurooncol 86:313–319CrossRefPubMed
23.
go back to reference Kaplan AM, Albright AL, Zimmerman RA, Rorke LB, Li H, Boyett JM, Finlay JL, Wara WM, Packer RJ (1996) Brainstem gliomas in children—A Children’s Cancer Group review of 119 cases. Pediatr Neurosurg 24:185–192CrossRefPubMed Kaplan AM, Albright AL, Zimmerman RA, Rorke LB, Li H, Boyett JM, Finlay JL, Wara WM, Packer RJ (1996) Brainstem gliomas in children—A Children’s Cancer Group review of 119 cases. Pediatr Neurosurg 24:185–192CrossRefPubMed
24.
go back to reference Packer RJ, Boyett JM, Zimmerman RA, Rorke LB, Kaplan AM, Albright AL, Selch MT, Finlay JL, Hammond GD, Wara WM (1993) Hyperfractionated radiation therapy (72 Gy) for children with brain stem gliomas. A childrens cancer group phase I/II trial. Cancer 72:1414–1421CrossRefPubMed Packer RJ, Boyett JM, Zimmerman RA, Rorke LB, Kaplan AM, Albright AL, Selch MT, Finlay JL, Hammond GD, Wara WM (1993) Hyperfractionated radiation therapy (72 Gy) for children with brain stem gliomas. A childrens cancer group phase I/II trial. Cancer 72:1414–1421CrossRefPubMed
25.
go back to reference Smith RR, Zimmerman RA, Packer RJ, Hackney DB, Bilaniuk LT, Sutton LN, Goldberg HI, Grossman RI, Schut L (1990) Pediatric brainstem glioma. Post-radiation clinical and MR follow-up. Neuroradiology 32:265–271CrossRefPubMed Smith RR, Zimmerman RA, Packer RJ, Hackney DB, Bilaniuk LT, Sutton LN, Goldberg HI, Grossman RI, Schut L (1990) Pediatric brainstem glioma. Post-radiation clinical and MR follow-up. Neuroradiology 32:265–271CrossRefPubMed
26.
go back to reference Koike S, Aida N, Hata M, Fujita K, Ozawa Y, Inoue T (2004) Asymptomatic radiation-induced telangiectasia in children after cranial irradiation: frequency, latency, and dose relation. Radiology 230:93–99CrossRefPubMed Koike S, Aida N, Hata M, Fujita K, Ozawa Y, Inoue T (2004) Asymptomatic radiation-induced telangiectasia in children after cranial irradiation: frequency, latency, and dose relation. Radiology 230:93–99CrossRefPubMed
27.
go back to reference Bagley LJ, Grossman RI, Judy KD, Curtis M, Loevner LA, Polansky M, Detre J (1997) Gliomas: correlation of magnetic susceptibility artifact with histologic grade. Radiology 202:511–516PubMed Bagley LJ, Grossman RI, Judy KD, Curtis M, Loevner LA, Polansky M, Detre J (1997) Gliomas: correlation of magnetic susceptibility artifact with histologic grade. Radiology 202:511–516PubMed
28.
go back to reference Deistung A, Rauscher A, Sedlacik J, Stadler J, Witoszynskyj S, Reichenbach JR (2008) Susceptibility weighted imaging at ultra high magnetic field strengths: theoretical considerations and experimental results. Magn Reson Med 60:1155–1168CrossRefPubMed Deistung A, Rauscher A, Sedlacik J, Stadler J, Witoszynskyj S, Reichenbach JR (2008) Susceptibility weighted imaging at ultra high magnetic field strengths: theoretical considerations and experimental results. Magn Reson Med 60:1155–1168CrossRefPubMed
29.
go back to reference Sedlacik J, Kutschbach C, Rauscher A, Deistung A, Reichenbach JR (2008) Investigation of the influence of carbon dioxide concentrations on cerebral physiology by susceptibility-weighted magnetic resonance imaging (SWI). Neuroimage 43:36–43CrossRefPubMed Sedlacik J, Kutschbach C, Rauscher A, Deistung A, Reichenbach JR (2008) Investigation of the influence of carbon dioxide concentrations on cerebral physiology by susceptibility-weighted magnetic resonance imaging (SWI). Neuroimage 43:36–43CrossRefPubMed
30.
go back to reference Nandigam RN, Viswanathan A, Delgado P, Skehan ME, Smith EE, Rosand J, Greenberg SM, Dickerson BC (2009) MR imaging detection of cerebral microbleeds: effect of susceptibility-weighted imaging, section thickness, and field strength. AJNR Am J Neuroradiol 30:338–343CrossRefPubMed Nandigam RN, Viswanathan A, Delgado P, Skehan ME, Smith EE, Rosand J, Greenberg SM, Dickerson BC (2009) MR imaging detection of cerebral microbleeds: effect of susceptibility-weighted imaging, section thickness, and field strength. AJNR Am J Neuroradiol 30:338–343CrossRefPubMed
Metadata
Title
Three-dimensional susceptibility-weighted imaging and two-dimensional T2*-weighted gradient-echo imaging of intratumoral hemorrhages in pediatric diffuse intrinsic pontine glioma
Authors
Ulrike Löbel
Jan Sedlacik
Noah D. Sabin
Mehmet Kocak
Alberto Broniscer
Claudia M. Hillenbrand
Zoltán Patay
Publication date
01-12-2010
Publisher
Springer-Verlag
Published in
Neuroradiology / Issue 12/2010
Print ISSN: 0028-3940
Electronic ISSN: 1432-1920
DOI
https://doi.org/10.1007/s00234-010-0771-9

Other articles of this Issue 12/2010

Neuroradiology 12/2010 Go to the issue